Prophylactic house dust mite Allergen immunotherapy clinical trials

Prevention of childhood asthma using house dust mite allergen tablets

This study looks at whether a daily tablet can help stop babies at risk of asthma from developing it. We’re testing a treatment that aims to make children less sensitive to house dust mites, a common cause of asthma. It's for babies aged 5-12 months with a family history of allergies.